Biotechnology in France

Introduction

Biotechnology in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.

*The French biotechnology market had total revenue of $4,674.9 million in 2010, representing a compound annual growth rate (CAGR) of 7.6% between 2006 and 2010.

*Medical/Healthcare sales proved the most lucrative for the French biotechnology market in 2010, with total revenues of $3,832.3 million, equivalent to 82% of the market's overall value.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 5.8% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $6,187.6 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in France

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in France

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the France biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the France economy

Key Questions Answered

What was the size of the France biotechnology market by value in 2010?

What will be the size of the France biotechnology market in 2015?

What factors are affecting the strength of competition in the France biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up France's biotechnology market?
[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
LEADING COMPANIES 19
Biomerieux SA 19
Merck KGaA 23
Transgene 26
MARKET FORECASTS 30
Market value forecast 30
MACROECONOMIC INDICATORS 31
APPENDIX 33
Methodology 33
Industry associations 34
Related Datamonitor research 34
Disclaimer 35
ABOUT DATAMONITOR 36
Premium Reports 36
Summary Reports 36
Datamonitor consulting 36

LIST OF TABLES
Table 1: France biotechnology market value: $ million, 2006–10 10
Table 2: France biotechnology market segmentation I:% share, by value, 2010 11
Table 3: France biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Biomerieux SA: key facts 19
Table 5: Biomerieux SA: key financials ($) 20
Table 6: Biomerieux SA: key financials (€) 20
Table 7: Biomerieux SA: key financial ratios 21
Table 8: Merck KGaA: key facts 23
Table 9: Merck KGaA: key financials ($) 24
Table 10: Merck KGaA: key financials (€) 24
Table 11: Merck KGaA: key financial ratios 24
Table 12: Transgene: key facts 26
Table 13: Transgene: key financials ($) 27
Table 14: Transgene: key financial ratios 28
Table 15: France biotechnology market value forecast: $ million, 2010–15 30
Table 16: France size of population (million), 2006–10 31
Table 17: France gdp (constant 2000 prices, $ billion), 2006–10 31
Table 18: France gdp (current prices, $ billion), 2006–10 31
Table 19: France inflation, 2006–10 32
Table 20: France consumer price index (absolute), 2006–10 32
Table 21: France exchange rate, 2006–10 32

LIST OF FIGURES
Figure 1: France biotechnology market value: $ million, 2006–10 10
Figure 2: France biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: France biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in France, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in France, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in France, 2010 15
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in France, 2010 16
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in France, 2010 17
Figure 9: Drivers of degree of rivalry in the biotechnology market in France, 2010 18
Figure 10: Biomerieux SA: revenues & profitability 21
Figure 11: Biomerieux SA: assets & liabilities 22
Figure 12: Merck KGaA: revenues & profitability 25
Figure 13: Merck KGaA: assets & liabilities 25
Figure 14: Transgene: revenues & profitability 28
Figure 15: Transgene: assets & liabilities 29
Figure 16: France biotechnology market value forecast: $ million, 2010–15 30


[Inhaltsverzeichnis ausblenden]